PortfoliosLab logoPortfoliosLab logo
INO vs. BORR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

INO vs. BORR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Inovio Pharmaceuticals, Inc. (INO) and Borr Drilling Ltd (BORR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, INO achieves a -36.21% return, which is significantly lower than BORR's 7.69% return.


INO

1D
-0.45%
1M
-17.78%
YTD
-36.21%
6M
-50.67%
1Y
-43.37%
3Y*
-40.23%
5Y*
-59.69%
10Y*
-36.85%

BORR

1D
2.84%
1M
-21.38%
YTD
7.69%
6M
8.77%
1Y
108.65%
3Y*
-10.35%
5Y*
21.51%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

INO vs. BORR - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
INO
Inovio Pharmaceuticals, Inc.
-36.21%-4.92%-70.10%-67.31%-68.74%-43.62%168.18%-17.50%-16.84%
BORR
Borr Drilling Ltd
7.69%4.15%-44.49%48.09%141.26%26.50%-91.00%-26.12%-54.21%

Correlation

The correlation between INO and BORR is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.17

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.15

Correlation (All Time)
Calculated using the full available price history since May 22, 2018

0.12

Fundamentals

Market Cap

INO:

$767.03M

BORR:

$1.34B

EPS

INO:

-$63.15

BORR:

$0.12

PB Ratio

INO:

0.13

BORR:

1.12

Total Revenue (TTM)

INO:

$0.00

BORR:

$1.05B

Gross Profit (TTM)

INO:

-$1.50M

BORR:

$483.30M

EBITDA (TTM)

INO:

-$22.01B

BORR:

$417.40M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

INO vs. BORR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INO
INO Risk / Return Rank: 2121
Overall Rank
INO Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
INO Sortino Ratio Rank: 2727
Sortino Ratio Rank
INO Omega Ratio Rank: 2525
Omega Ratio Rank
INO Calmar Ratio Rank: 1717
Calmar Ratio Rank
INO Martin Ratio Rank: 1818
Martin Ratio Rank

BORR
BORR Risk / Return Rank: 8484
Overall Rank
BORR Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
BORR Sortino Ratio Rank: 8282
Sortino Ratio Rank
BORR Omega Ratio Rank: 7979
Omega Ratio Rank
BORR Calmar Ratio Rank: 8383
Calmar Ratio Rank
BORR Martin Ratio Rank: 8888
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INO vs. BORR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Inovio Pharmaceuticals, Inc. (INO) and Borr Drilling Ltd (BORR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


INOBORRDifference
Sharpe ratioReturn per unit of total volatility

-2.28

Sortino ratioReturn per unit of downside risk

-2.59

Omega ratioGain probability vs. loss probability

0.97

1.29

-0.32

Calmar ratioReturn relative to maximum drawdown

-0.69

3.02

-3.71

Martin ratioReturn relative to average drawdown

-1.11

10.03

-11.13

INO vs. BORR - Sharpe Ratio Comparison

The current INO Sharpe Ratio is -0.50, which is lower than the BORR Sharpe Ratio of 1.79. The chart below compares the historical Sharpe Ratios of INO and BORR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

INO vs. BORR - Drawdown Comparison

The maximum INO drawdown since its inception was -99.95%, roughly equal to the maximum BORR drawdown of -99.07%. Use the drawdown chart below to compare losses from any high point for INO and BORR.


Loading charts...

Drawdown Indicators


INOBORRDifference

Max Drawdown

Largest peak-to-trough decline

-99.95%

-99.07%

-0.88%

Max Drawdown (1Y)

Largest decline over 1 year

-63.41%

-36.16%

-27.25%

Max Drawdown (3Y)

Largest decline over 3 years

-92.44%

-80.90%

-11.54%

Max Drawdown (5Y)

Largest decline over 5 years

-99.10%

-80.90%

-18.20%

Max Drawdown (10Y)

Largest decline over 10 years

-99.72%

Current Drawdown

Current decline from peak

-99.95%

-91.43%

-8.52%

Average Drawdown

Average peak-to-trough decline

-92.35%

-88.79%

-3.56%

Ulcer Index

Depth and duration of drawdowns from previous peaks

39.27%

10.94%

+28.33%

Volatility

INO vs. BORR - Volatility Comparison

Inovio Pharmaceuticals, Inc. (INO) and Borr Drilling Ltd (BORR) have volatilities of 16.85% and 16.54%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


INOBORRDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.85%

16.54%

+0.31%

Volatility (6M)

Calculated over the trailing 6-month period

64.19%

36.95%

+27.24%

Volatility (1Y)

Calculated over the trailing 1-year period

87.98%

61.19%

+26.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

85.67%

72.26%

+13.41%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

93.33%

118.52%

-25.19%

Dividends

INO vs. BORR - Dividend Comparison

Neither INO nor BORR has paid dividends to shareholders.


PositionTTM20252024
BORR
Borr Drilling Ltd
0.00%0.50%7.69%
INO
Inovio Pharmaceuticals, Inc.
0.00%0.00%0.00%

Financials

INO vs. BORR - Financials Comparison

This section allows you to compare key financial metrics between Inovio Pharmaceuticals, Inc. and Borr Drilling Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M202220232024202520260
247.00M
(INO) Total Revenue
(BORR) Total Revenue
Values in USD except per share items

Frequently Asked Questions


INO and BORR have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

INO has higher volatility (16.85%) compared to BORR (16.54%). In terms of maximum drawdown, INO dropped -99.95% vs BORR's -99.07%.

BORR currently has the higher Sharpe Ratio (1.79 vs -0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for INO and BORR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer